AveXis to Report Topline Phase 1 Trial Results in SMA Type

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
29
AveXis to Report Topline Phase 1 Trial Results in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results on March 16, 2017

-- Conference call and webcast on March 16 at 4:30 p.m. EDT --

CHICAGO, March 09, 2017 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, will announce topline results from the Phase 1 clinical trial of AVXS-101 in patients with SMA Type 1, and financial and operating results for the fourth quarter and full year ended December 31, 2016 on Thursday, March 16, 2017 after the close of U.S.-based financial markets. AveXis management will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time.

Analysts and investors can participate in the conference call by dialing (844) 889-6863 for domestic callers and (661) 378-9762 for international callers, using the conference ID 84652584. The webcast can be accessed live on the Events and Presentations page in the Investors and Media section of the AveXis website, www.AveXis.com .  The webcast will be archived on the company’s website until its next quarterly earnings call, and will be available for telephonic replay for 14 days following the call by dialing (855) 859-2056 (Domestic) or (404) 537-3406 (International), conference ID 84652584.

About SMA SMA is a severe neuromuscular disease characterized by the loss of motor neurons leading to progressive muscle weakness and paralysis. SMA is caused by a genetic defect in the SMN1 gene that codes SMN, a protein necessary for survival of motor neurons. The incidence of SMA is approximately one in 10,000 live births.

The most severe form of SMA is Type 1, a lethal genetic disorder characterized by motor neuron loss and associated muscle deterioration, which results in mortality or the need for permanent ventilation support before the age of two for greater than 90 percent of patients. SMA Type 1 is the leading genetic cause of infant mortality.

About AVXS-101 AVXS-101 is a proprietary gene therapy candidate of a one-time treatment for SMA Type 1 and is currently in development for SMA. AVXS-101 is designed to address the monogenic root cause of SMA and prevent further muscle degeneration by addressing the defective and/or loss of the primary SMN1 gene. AVXS-101 also targets motor neurons providing rapid onset of effect and crosses the blood brain barrier allowing an IV dosing route and effective targeting of both central and systemic features.

About AveXis, Inc. AveXis is a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases. The company’s initial proprietary gene therapy candidate, AVXS-101, is in an ongoing Phase 1 clinical trial for the treatment of SMA Type 1. For additional information, please visit www.avexis.com.

 

Media Inquiries: Lauren Barbiero W2O Group 646-564-2156 lbarbiero@w2ogroup.com Investor Inquiries: Jim Goff AveXis, Inc. 650-862-4134 jgoff@avexis.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Data Centers: More Power-Hungry Than Thirsty

Updated Category News Views 134

Data Centers: Not Quite the Water Guzzlers We Feared Hold onto your hats, because the latest intel on data centers is changing the game, or at least forcing a closer look at what seems like a done deal. The big reveal? It's not the water, folks—it’s the juice. While everyone frets about water, electricity is the silent giant you’ve got to wrangle. Water vs....

Continue Reading
Fitness Career Platform's Big Ramp Up Sparks Buzz

Updated Category News Views 116

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Continue Reading
Shorr Packaging's Sustainable Edge: EcoVadis Silver Triumph

Updated Category News Views 119

EcoVadis Silver Badge: Shorr's Green Path Imagine this: Shorr Packaging strutting around with an EcoVadis Silver Badge pinned to its chest for not one, not two, but three years now. That's right, Shorr Packaging's been elbowing its way to the top tier with their sustainability drive, ranked in the 93rd percentile. For those not keeping score, that's top-notch, considering...

Continue Reading
Monotype's Inkwell: A Type Family with New Twists

Updated Category News Views 72

Fresh Faces in the World of Type Out of the design trenches comes news that Monotype—the big cheese in type and tech—just rolled out four new styles in its well-liked Inkwell lineup. We're talking Inkwell Antique, Formal, Chancery, and Ornaments here. The idea? Give designers more room to play with tone. Let's chew on what this expansion means for folks rocking...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 80

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 150

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
Innovative Rotating Kitchen Organizer Up for Licensing

Updated Category News Views 76

Dusting Off the Corners: A Fresh Spin on Kitchen Storage Just when you think there's nothing new under the sun when it comes to storing your kitchen gadgets, here comes an invention straight out of Billings, Montana. It's called The Rotating Kitchen Organizer, a nifty contraption that's all set to turn those dead corners into prime real estate. How many times have we...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 178

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Business Boom in 2026: Key Regions to Watch Now

Updated Category News Views 114

Business Formations Break Records in 2026 I'm telling you, the entrepreneurial spirit is alive and kicking across the States this year. The latest numbers from Registered Agents Inc are clear as day: business is bustling. We're looking at 576,818 new business setups nationwide just in October 2026. That's outpacing the previous year by a whopping 8%. And if that doesn't...

Continue Reading
$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 155

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading

Top 5 Most Recently Viewed Articles

Milberg Advances Legal Battle Against Big Oil's Deception

Updated Category News Views 404

Milberg's Lawsuit Against Fossil Fuel Giants In a significant development for climate justice, a federal magistrate judge has made a ruling that allows the crucial lawsuit initiated by municipalities in Puerto Rico against major fossil fuel companies to move ahead. This legal battle is founded on the Racketeer Influenced and Corrupt Organizations Act (RICO) and aims to...

Continue Reading
Investors of MGP Ingredients, Inc. Explore Legal Action Options

Updated Category News Views 100

Investors of MGP Ingredients, Inc. Explore Legal Action Options MGP Ingredients, Inc. (MGPI) offers an important opportunity for investors who faced losses due to securities fraud. In light of recent events, affected shareholders are urged to take action and consider leading a class action lawsuit. This situation underscores the importance of staying informed about your...

Continue Reading
Dialysis Market Growth Driven by Chronic Kidney Disease Rise

Updated Category News Views 72

Overview of the Dialysis Market Growth The healthcare landscape is witnessing a notable increase in the demand for dialysis, which is expected to grow at a compound annual growth rate (CAGR) of 7.7% over the next few years. This growth is primarily driven by the rising number of diabetes and hypertension cases across the globe. With a stronger emphasis on managing chronic...

Continue Reading
Pollen Street Group Welcomes Crispin Goldsmith as CFO

Updated Category News Views 208

Pollen Street Group Welcomes New Chief Financial Officer Pollen Street Group Limited has made a significant move by appointing Crispin Goldsmith as its new Chief Financial Officer (CFO). This appointment reflects the company's commitment to strengthening its leadership team and enhancing its strategic direction. Goldsmith's Extensive Experience Crispin Goldsmith is no...

Continue Reading
Celebrating Probiotic Innovation: Join the 30-Day Gut Challenge

Updated Category News Views 147

Celebrating 30 Years of Probiotic Innovation Bio-K+, a leader in probiotic healthcare, is thrilled to announce the launch of its 30-Day Gut Challenge. This exciting initiative marks the brand's significant milestone of 30 years devoted to advancing gut health through scientific research. The campaign encourages individuals to embrace healthier daily practices and...

Continue Reading